Literature DB >> 11201341

Long-acting delivery microspheres of levo-norgestrol-poly(3-hydroxybutyrate): their preparation, characterization and contraceptive tests on mice.

B Lu1, Z R Wang, H Yang.   

Abstract

The preparative technology for sustained release drug delivery microspheres of levo-norgestrol-poly(3-hydroxybutyrate) was optimized based on the in-liquid-drying method. The formation of the drug microspheres was confirmed with differential thermal analysis. The appearance, particle size and distribution, residual CHCl3, drug content, drug release characteristics in vitro, stability and anticonceptive effect on mice of the microspheres were all examined. The average particle size was 64 microm with over 90% of the microspheres being in the range of 28.7-85.8 microm. The residual CHCl3 was lower than 0.001%. The drug release behaviour in vitro could be described by the Higuchi equation and the drug release t1/2 was prolonged by 1.8 times, compared with the original drug LNG. The microspheres were stable for 3 months and showed significant sustained release and anticonceptive effect in mice, and lower toxicity compared with the original drug.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11201341     DOI: 10.1080/026520401750038601

Source DB:  PubMed          Journal:  J Microencapsul        ISSN: 0265-2048            Impact factor:   3.142


  3 in total

1.  Biocompatibility of polyhydroxybutyrate microspheres: in vitro and in vivo evaluation.

Authors:  Ekaterina Igorevna Shishatskaya; Olga N Voinova; Anastasiya V Goreva; Olga A Mogilnaya; Tatiana G Volova
Journal:  J Mater Sci Mater Med       Date:  2008-02-06       Impact factor: 3.896

Review 2.  Long-acting injectable hormonal dosage forms for contraception.

Authors:  Linfeng Wu; Dileep R Janagam; Timothy D Mandrell; James R Johnson; Tao L Lowe
Journal:  Pharm Res       Date:  2015-04-22       Impact factor: 4.200

3.  Microparticles prepared from biodegradable polyhydroxyalkanoates as matrix for encapsulation of cytostatic drug.

Authors:  A V Murueva; E I Shishatskaya; A M Kuzmina; T G Volova; A J Sinskey
Journal:  J Mater Sci Mater Med       Date:  2013-05-15       Impact factor: 3.896

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.